Ingested (oral) neuropeptide Y inhibits EAE

Journal of Neuroimmunology

Volumn 250, Issue 1-2, 2012, Pages 44-49

  Brod, Staley A ^a   Bauer, Victoria L ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Adoptive transfer; EAE; Neuropeptide Y; Oral proteins

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; METHIONYLGLUTAMYLVALYLGLYCYLTRYPTOPHYLTYROSYLARGINYLSERYLPROLYLPHENYLALANYLSERYLARGINYLVALYLVALYLHISTIDYLLEUCYLTYROSYLARGINYLASPARAGYLGLYCYLLYSINE; NEUROPEPTIDE Y; PEPTIDE; PLACEBO; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CD4+ CD25+ FOXP3+ REGULATORY T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE RELEASE; FEEDING; FEMALE; IMMUNOMODULATION; IN VIVO STUDY; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECIPIENT; REGULATORY T LYMPHOCYTE; SPLEEN; SPLEEN CELL; TH1 CELL; TH17 CELL; TH2 CELL;

ADMINISTRATION, ORAL; ADOPTIVE TRANSFER; ANIMALS; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; MICE; MICE, INBRED C57BL; NEUROPEPTIDE Y; SPINAL CORD;

EID: 84864858939     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2012.05.015     Document Type: Article

References (43)

1. Alvord E.C., Shaw C.M., Huby S., Kies M.K. Encephalitogen-induced inhibition of experimental allergic encephalomyelitis: prevention, suppression, and therapy. Ann. N.Y. Acad. Sci. 1965, 122:333-345.
2. Awaad A., Nakamura M., Ishimura K. Imaging of size-dependent uptake and identification of novel pathways in mouse Peyer's patches using fluorescent organosilica particles. Nanomedicine 2011, 10.1016/j.nano.2011.08.009, PII:S1549-9634(11)00346-7.
3. Bedoui S., Kawamura N., Straub R.H., Pabst R., Yamamura T., von Horsten S. Relevance of neuropeptide Y for the neuroimmune crosstalk. J. Neuroimmunol. 2003, 134:1-11.
4. Bedoui S., Miyake S., Lin Y., Miyamoto K., Oki S., Kawamura N., Beck-Sickinger A., von Horsten S., Yamamura T. Neuropeptide Y (NPY) suppresses experimental autoimmune encephalomyelitis: NPY1 receptor-specific inhibition of autoreactive Th1 responses in vivo. J. Immunol. 2003, 171:3451-3458.
5. Bocci V. Is interferon effective after oral administration? The state of the art. J. Biol. Regul. Homeost. Agents 1990, 4:81-83.
6. Bocci V. Absorption of cytokines via the oropharyngeal associated lymphoid tissues - does an unorthodox route improve the therapeutic index of interferon. Clin. Pharmacokinet. 1991, 21:411-417.
7. Brod S.A., Burns D.K. Suppression of relapsing experimental autoimmune encephalomyelitis in the SJL/J mouse by oral administration of type I interferons. Neurology 1994, 44:1144-1148.
8. Brod S.A., Hood Z. Ingested (oral) SIRS peptide 1-21 inhibits acute EAE by inducing Th(2)-like cytokines. J. Neuroimmunol. 2007, 183:89-95.
9. Brod S.A., Hood Z.M. Ingested (oral) alpha-MSH inhibits acute EAE. J. Neuroimmunol. 2008, 193:106-112.
10. Brod S.A., Hood Z.M. Ingested (oral) ACTH inhibits EAE. J. Neuroimmunol. 2011, 232:131-135.
11. Brod S.A., Hood Z.M. Ingested (oral) SST inhibits EAE. Autoimmunity 2011, 44:437-443.
12. Brod S.A., Khan M. Oral administration of IFN-alpha is superior to subcutaneous administration of IFN-alpha in the suppression of chronic relapsing experimental autoimmune encephalomyelitis. J. Autoimmun. 1996, 9:11-20.
13. Brod S.A., Khan M., Kerman R.H., Pappolla M. Oral administration of human or murine interferon alpha suppresses relapses and modifies adoptive transfer in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 1995, 58:61-69.
14. De la Fuente M., Bernaez I., Del Rio M., Hernanz A. Stimulation of murine peritoneal macrophage functions by neuropeptide Y and peptide YY. Involvement of protein kinase C. Immunology 1993, 80:259-265.
15. De la Fuente M., Del Rio M., Medina S. Changes with aging in the modulation by neuropeptide Y of murine peritoneal macrophage functions. J. Neuroimmunol. 2001, 116:156-167.
16. De la Fuente M., Del Rio M., Victor V.M., Medina S. Neuropeptide Y effects on murine natural killer activity: changes with ageing and cAMP involvement. Regul. Pept. 2001, 101:73-79.
17. Dong C. Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells. Nat. Rev. Immunol. 2006, 6:329-333.
18. Eantuzzi L., Eid P., Malorni W., Rainaldi G., Gauzzi M., Pellegrini S., Belardelli F., Gessani S. Post-translational up-regulation of the cell surface-associated alpha component of the human type I interferon receptor during differentiation of peripheral blood monocytes: role in the biological response to type I interferon. Eur. J. Immunol. 1997, 27:1075-1081.
19. Ferreira R., Xapelli S., Santos T., Silva A.P., Cristovao A., Cortes L., Malva J.O. Neuropeptide Y modulation of interleukin-1{beta} (IL-1{beta})-induced nitric oxide production in microglia. J. Biol. Chem. 2010, 285:41921-41934.
20. Ferreira R., Santos T., Cortes L., Cochaud S., Agasse F., Silva A.P., Xapelli S., Malva J.O. Neuropeptide Y inhibits interleukin-1 beta (IL-1beta)-induced microglia motility. J. Biol. Chem. 2011, 285:41921-41934.
21. Feuer C., Prentice D.E., Cammisuli S. Chronic relapsing experimental allergic encephalomyelitis in the Lewis rat. J. Neuroimmunol. 1985, 10:159-166.
22. Gaffen S.L., Kramer J.M., Yu J.J., Shen F. The IL-17 cytokine family. Vitam. Horm. 2006, 74:255-282.
23. Hashimoto R., Udagawa J., Kagohashi Y., Matsumoto A., Hatta T., Otani H. Direct and indirect effects of neuropeptide Y and neurotrophin 3 on myelination in the neonatal brains. Brain Res. 2011, 1373:55-66.
24. Issazadeh S., Mustafa M., Ljungdahl A., Hojeberg B., Dagerlind A., Elde R., Olsson T. Interferon gamma, interleukin 4 and transforming growth factor beta in experimental autoimmune encephalomyelitis in Lewis rats: dynamics of cellular mRNA expression in the central nervous system and lymphoid cells. J. Neurosci. Res. 1995, 40:579-590.
25. Kawamura N., Tamura H., Obana S., Wenner M., Ishikawa T., Nakata A., Yamamoto H. Differential effects of neuropeptides on cytokine production by mouse helper T cell subsets. Neuroimmunomodulation 1998, 5:9-15.
26. Levite M. Neuropeptides, by direct interaction with T cells, induce cytokine secretion and break the commitment to a distinct T helper phenotype. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:12544-12549.
27. Maeda K., Yasuda M., Kaneda H., Maeda S., Yamadori A. Cerebrospinal fluid (CSF) neuropeptide Y- and somatostatin-like immunoreactivities in man. Neuropeptides 1994, 27:323-332.
28. Malefyt R., Haanen J., Spits H., Roncarolo M.-G., te Velde A., Figdor C., de Vries J. IL-10 and viral IL-10 strongly reduce antigen specific human T cell proliferation by diminishing the antigen presenting capacity of monocytes via downregulation of class II MHC expression. J. Exp. Med. 1991, 174:915-924.
29. Mitic K., Stanojevic S., Kustrimovic N., Vujic V., Dimitrijevic M. Neuropeptide Y modulates functions of inflammatory cells in the rat: distinct role for Y1, Y2 and Y5 receptors. Peptides 2011, 32:1626-1633.
30. Monney L., Sabatos C.A., Gaglia J.L., Ryu A., Waldner H., Chernova T., Manning S., Greenfield E.A., Coyle A.J., Sobel R.A., Freeman G.J., Kuchroo V.K. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 2002, 415:536-541.
31. Murphy A.C., Lalor S.J., Lynch M.A., Mills K.H. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis. Brain Behav. Immun. 2010, 24:641-651.
32. Offner H., Subramanian S., Wang C., Afentoulis M., Vandenbark A.A., Huan J., Burrows G.G. Treatment of passive experimental autoimmune encephalomyelitis in SJL mice with a recombinant TCR ligand induces IL-13 and prevents axonal injury. J. Immunol. 2005, 175:4103-4111.
33. Raine C.S., Stone S.H. Animal models for multiple sclerosis: chronic experimental allergic encephalomyelitis in inbred guinea pigs. N.Y. State J. Med. 1977, 77:1693-1696.
34. Renno T., Krakowski M., Piccirillo C., Lin L., Owens T. TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines. J. Immunol. 1995, 154:944-953.
35. Rollwagen R., Baqar S. Oral cytokine administration. Immunol. Today 1996, 17:548-550.
36. Shreedhar V.K., Kelsall B.L., Neutra M.R. Cholera toxin induces migration of dendritic cells from the subepithelial dome region to T- and B-cell areas of Peyer's patches. Infect. Immun. 2003, 71:504-509.
37. Soni J., Baird A.W., O'Brien L.M., McElroy M., Callanan J.J., Bassett H.F., Campion D., Brayden D.J. Rat, ovine and bovine Peyer's patches mounted in horizontal diffusion chambers display sampling function. J. Control. Release 2006, 115:68-77.
38. Sutton C., Brereton C., Keogh B., Mills K.H., Lavelle E.C. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 2006, 203:1685-1691.
39. Takahashi T., Ichinose M., Yamauchi H., Miura M., Nakajima N., Ishikawa J., Inoue H., Takishima T., Shirato K. Neuropeptide Y inhibits neurogenic inflammation in guinea pig airways. J. Appl. Physiol. 1993, 75:103-107.
40. Tompkins S.M., Padilla J., Dal Canto M.C., Ting J.P., Van Kaer L., Miller S.D. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis. J. Immunol. 2002, 168:4173-4183.
41. Wheway J., Mackay C.R., Newton R.A., Sainsbury A., Boey D., Herzog H., Mackay F. A fundamental bimodal role for neuropeptide Y1 receptor in the immune system. J. Exp. Med. 2005, 202:1527-1538.
42. Wisnewski H.M., Keith A.B. Chronic relapsing experimental allergic encephalomyelitis: an experimental model of multiple sclerosis. Ann. Neurol. 1977, 1:144-148.
43. ser. J. Interferon Res. 1992, 12:411-413.